/
SMMT
$13.35-$0.65 (-4.64%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$12.0B
798M shares
52-week range
$12.25 – $30.05
6% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change+$5.89
Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
www.smmttx.com- Employees
- 265
- IPO / List date
- Mar 5, 2015
- HQ
- MIAMI, FL
Held by traders on TradeandTell
No one on the platform currently holds SMMT.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SMMT as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded SMMT yet.
